Exane Derivatives’s Mastercard MA Stock Holding History

Exane Derivatives’s Portfolio MA Stock Details MA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$320K	Sell	1,015 -860	-46%	-$296K	0.18%	127
2022 Q1	$670K	Sell	1,875 -203	-10%	-$73K	0.19%	142
2021 Q4	$747K	Sell	2,078 -970	-32%	-$335K	0.18%	125
2021 Q3	$1.06M	Sell	3,048 -188	-6%	-$68.4K	0.25%	82
2021 Q2	$1.24M	Buy	3,236 +1,522	+89%	+$566K	0.28%	79
2021 Q1	$610K	Buy	1,714 +132	+8%	+$46.1K	0.17%	127
2020 Q4	$565K	Buy	1,582 +915	+137%	+$304K	0.17%	133
2020 Q3	$226K	Sell	667 -42	-6%	-$13.7K	0.07%	206
2020 Q2	$210K	Buy	709 +661	+1,377%	+$186K	0.06%	210
2020 Q1	$11.6K	Sell	48 -1,783	-97%	-$530K	﹤0.01%	423
2019 Q4	$575K	Buy	1,831 +395	+28%	+$111K	0.11%	157
2019 Q3	$390K	Sell	1,436 -310	-18%	-$85.4K	0.07%	179
2019 Q2	$462K	Buy	1,746 +20	+1%	+$5K	0.08%	176
2019 Q1	$406K	Sell	1,726 -1,874	-52%	-$403K	0.08%	165
2018 Q4	$679K	Buy	3,600 +267	+8%	+$53K	0.12%	149
2018 Q3	$742K	Sell	3,333 -6,794	-67%	-$1.42M	0.14%	134
2018 Q2	$1.99M	Buy	10,127 +6,959	+220%	+$1.31M	0.33%	75
2018 Q1	$539K	Sell	3,168 -8,340	-72%	-$1.43M	0.11%	164
2017 Q4	$1.74M	Sell	11,508 -9,810	-46%	-$1.46M	0.3%	55
2017 Q3	$3.01M	Buy	21,318 +20,888	+4,858%	+$2.76M	0.56%	30
2017 Q2	$52.2K	Buy	430 +228	+113%	+$27K	0.01%	311
2017 Q1	$22.7K	Sell	202 -2,104	-91%	-$231K	0.01%	320
2016 Q4	$238K	Sell	2,306 -150	-6%	-$15.5K	0.05%	194
2016 Q3	$250K	Sell	2,456 -1,800	-42%	-$173K	0.04%	193
2016 Q2	$375K	Sell	4,256 -2,203	-34%	-$210K	0.06%	158
2016 Q1	$610K	Buy	6,459 +1,788	+38%	+$158K	0.08%	124
2015 Q4	$455K	Sell	4,671 -308	-6%	-$30.2K	0.06%	122
2015 Q3	$449K	Sell	4,979 -4,553	-48%	-$428K	0.06%	132
2015 Q2	$891K	Buy	9,532 +1,245	+15%	+$114K	0.1%	99
2015 Q1	$716K	Buy	8,287 +6,367	+332%	+$552K	0.08%	114
2014 Q4	$165K	Buy	+1,920	New	+$157K	0.02%	237

Other funds holding MA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's MA Position: Q2 2022 in Review

Exane Derivatives reduced its Mastercard (MA) stake by 46% in Q2 2022, selling an estimated $296K and leaving 1,015 shares worth $320K. The position accounts for 0.18% of the portfolio, ranked #127.

Exane Derivatives first reported a position in MA in Q4 2014 and has held it in 31 quarters since. The position peaked at $3.01M in Q3 2017. 2,589 funds tracked by Wall St. Rank hold MA as of Q2 2022.

Exane Derivatives held 1,015 shares of Mastercard worth $320K as of Q2 2022.
Exane Derivatives sold 860 Mastercard shares in Q2 2022, an estimated $296K.
Mastercard made up 0.18% of Exane Derivatives's portfolio in Q2 2022, its #127 holding.
Exane Derivatives first reported a position in Mastercard in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's Mastercard position peaked at $3.01M in Q3 2017.
2,589 funds tracked by Wall St. Rank held Mastercard as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.